Vimian Group (OM:VIMIAN) - Aktienkurs, Nachrichten und Analyse

VIMIAN Aktienübersicht

Vimian Group AB (publ) ist weltweit im Bereich der Tiergesundheit tätig.

VIMIAN grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	4/6
Künftiges Wachstum	4/6
Vergangene Leistung	2/6
Finanzielle Gesundheit	4/6
Dividenden	0/6

Belohnungen

35.9% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 58.58% pro Jahr

In diesem Jahr profitabel geworden

Risikoanalyse

Große einmalige Posten, die sich auf die Finanzergebnisse auswirken

Die Aktionäre wurden im vergangenen Jahr verwässert

Signifikante Insiderverkäufe in den letzten 3 Monaten

Vimian Group AB (publ) Wettbewerber

Xvivo Perfusion

OM:XVIVO

SEK 16.2b

Bactiguard Holding

OM:BACTI B

SEK 2.2b

OssDsign

OM:OSSD

SEK 681.7m

Elekta

OM:EKTA B

SEK 25.1b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Vimian Group
Historische Aktienkurse
Aktueller Aktienkurs	SEK 43.05
52-Wochen-Hoch	SEK 45.95
52-Wochen-Tief	SEK 20.08
Beta	1.62
11 Monat Veränderung	9.96%
3 Monate Veränderung	23.88%
1 Jahr Veränderung	77.89%
33 Jahre Veränderung	-53.93%
5 Jahre Veränderung	n/a
Veränderung seit IPO	-46.79%

Aktuelle Nachrichten und Updates

Revenues Not Telling The Story For Vimian Group AB (publ) (STO:VIMIAN) After Shares Rise 27%

Aug 31

Is Vimian Group (STO:VIMIAN) A Risky Investment?

Aug 17

Recent updates

Revenues Not Telling The Story For Vimian Group AB (publ) (STO:VIMIAN) After Shares Rise 27%

Aug 31

Is Vimian Group (STO:VIMIAN) A Risky Investment?

Aug 17

Vimian Group (STO:VIMIAN) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 18

Vimian Group AB (publ) (STO:VIMIAN) Shares Could Be 40% Below Their Intrinsic Value Estimate

Apr 09

There's Been No Shortage Of Growth Recently For Vimian Group's (STO:VIMIAN) Returns On Capital

Nov 01

Vimian Group AB (publ)'s (STO:VIMIAN) Intrinsic Value Is Potentially 92% Above Its Share Price

Aug 27

When Should You Buy Vimian Group AB (publ) (STO:VIMIAN)?

Jul 19

Are Investors Undervaluing Vimian Group AB (publ) (STO:VIMIAN) By 27%?

May 19

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Apr 04

Calculating The Intrinsic Value Of Vimian Group AB (publ) (STO:VIMIAN)

Jan 06

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Dec 09

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 38% Discount?

Aug 25

We Like These Underlying Return On Capital Trends At Vimian Group (STO:VIMIAN)

Jun 18

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 34% Discount?

May 19

Does This Valuation Of Vimian Group AB (publ) (STO:VIMIAN) Imply Investors Are Overpaying?

Feb 07

Risks Still Elevated At These Prices As Vimian Group AB (publ) (STO:VIMIAN) Shares Dive 28%

Nov 30

Aktionärsrenditen

	VIMIAN	SE Medical Equipment	SE Markt
7D	-1.1%	0.4%	1.6%
1Y	77.9%	17.6%	21.0%

Rendite im Vergleich zur Industrie: VIMIAN übertraf die Branche Swedish Medical Equipment , die im vergangenen Jahr eine Rendite von -2.2 erzielte.

Rendite vs. Markt: VIMIAN übertraf den Markt Swedish, der im vergangenen Jahr eine Rendite von 13.1 erzielte.

Preisvolatilität

Is VIMIAN's price volatile compared to industry and market?
VIMIAN volatility
VIMIAN Average Weekly Movement	7.2%
Medical Equipment Industry Average Movement	7.5%
Market Average Movement	5.6%
10% most volatile stocks in SE Market	11.8%
10% least volatile stocks in SE Market	3.2%

Stabiler Aktienkurs: VIMIANDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: VIMIANDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2020	1,100	Patrik Eriksson	vimian.com

Die Vimian Group AB (publ) ist weltweit im Bereich der Tiergesundheit tätig. Das Unternehmen ist in den Segmenten Specialty Pharma, MedTech, Diagnostics und Veterinary Services tätig. Unter dem Markennamen Nextmune bietet das Unternehmen eigene Diagnostika, verschreibungspflichtige und nicht verschreibungspflichtige Behandlungen für die präventive Pflege und die Behandlung chronischer Erkrankungen von Haustieren an.

Vimian Group AB (publ)'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Vimian Group im Vergleich zum Marktanteil des Unternehmens?
VIMIAN grundlegende Statistiken
Marktanteil	SEK 22.49b
Gewinn(TTM)	SEK 111.49m
Umsatz(TTM)	SEK 3.92b

201.7x

Kurs-Gewinn-Verhältnis

5.7x

Kurs-Umsatz-Verhältnis

Ist VIMIAN zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
VIMIAN Gewinn- und Verlustrechnung (TTM)
Einnahmen	€344.63m
Kosten der Einnahmen	€105.23m
Bruttogewinn	€239.40m
Sonstige Ausgaben	€229.58m
Umsatz	€9.81m

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

Oct 24, 2024

Gewinn per Aktie (EPS)	0.019
Bruttomarge	69.47%
Nettogewinnspanne	2.85%
Schulden/Eigenkapital-Verhältnis	25.1%

Wie hat sich VIMIAN auf lange Sicht entwickelt?

Historische Performance und Vergleiche

VIMIAN Aktienübersicht

Belohnungen

Risikoanalyse

Vimian Group AB (publ) Wettbewerber

OM:XVIVO

SEK 16.2b

OM:BACTI B

SEK 2.2b

OM:OSSD

SEK 681.7m

OM:EKTA B

SEK 25.1b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Consensus EPS estimates increase by 16%

Revenues Not Telling The Story For Vimian Group AB (publ) (STO:VIMIAN) After Shares Rise 27%

Consensus EPS estimates fall by 17%

Is Vimian Group (STO:VIMIAN) A Risky Investment?

Second quarter 2024 earnings: EPS misses analyst expectations

Chief Executive Officer of Nextmune recently sold kr3.6m worth of stock

Recent updates

Consensus EPS estimates increase by 16%

Revenues Not Telling The Story For Vimian Group AB (publ) (STO:VIMIAN) After Shares Rise 27%

Consensus EPS estimates fall by 17%

Is Vimian Group (STO:VIMIAN) A Risky Investment?

Second quarter 2024 earnings: EPS misses analyst expectations

Chief Executive Officer of Nextmune recently sold kr3.6m worth of stock

Director recently bought kr10m worth of stock

Vimian Group AB (publ) Elects Magnus Welander to Board as Chairman of the Board

New minor risk - Earnings quality

Independent Director recently bought kr386k worth of stock

Consensus EPS estimates fall by 24%

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Vimian Group (STO:VIMIAN) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2023 earnings: EPS misses analyst expectations

Vimian Group AB (publ) (STO:VIMIAN) Shares Could Be 40% Below Their Intrinsic Value Estimate

Vimian Group AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 1.632566 billion.

Full year 2023 earnings released: EPS: €0.022 (vs €0.017 loss in FY 2022)

Vimian Group (STO:VIMIAN) Is Experiencing Growth In Returns On Capital

Little Excitement Around Vimian Group AB (publ)'s (STO:VIMIAN) Revenues

Vimian Group AB (publ) Announces CEO Changes

Why Vimian Group AB (publ) (STO:VIMIAN) Could Be Worth Watching

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

There's Been No Shortage Of Growth Recently For Vimian Group's (STO:VIMIAN) Returns On Capital

Fidelio Capital acquired a 12% stake in Vimian Group AB (publ) for approximately SEK 240 million.

Chairman of the board recently bought kr235m worth of stock

Vimian Group AB (publ) to Report Q3, 2024 Results on Oct 24, 2024

Vimian Group AB (publ)'s (STO:VIMIAN) Intrinsic Value Is Potentially 92% Above Its Share Price

New major risk - Financial position

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

When Should You Buy Vimian Group AB (publ) (STO:VIMIAN)?

Chief Executive Officer recently bought kr605k worth of stock

Vimian Group AB (publ) Announces Fredrik Ullman Step Down as CEO

Vimian Group AB (Publ) Elects Robert Belkic as New Board Member

Are Investors Undervaluing Vimian Group AB (publ) (STO:VIMIAN) By 27%?

Full year 2022 earnings released: €0.017 loss per share (vs €0.019 profit in FY 2021)

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Chief Executive Officer recently bought kr1.1m worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 23% undervalued after recent price drop

Calculating The Intrinsic Value Of Vimian Group AB (publ) (STO:VIMIAN)

Investor sentiment deteriorated over the past week

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

Third quarter 2022 earnings released

Vimian Group AB (publ) to Report Q2, 2023 Results on Aug 17, 2023

High number of new and inexperienced directors

Vimian Group AB (publ), Annual General Meeting, Jun 01, 2023

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Vimian Appoints Carl-Johan Ehn as General Counsel and Member of the Vimian Group Management Team

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 38% Discount?

Second quarter 2022 earnings: Revenues exceed analyst expectations

Vimian Group AB (publ) (OM:VIMIAN) acquired Heiland Gmbh.

Vimian Group AB (publ) Appoints Carl-Johan Zetterberg Boudrie as CFO and Member of Management Team

We Like These Underlying Return On Capital Trends At Vimian Group (STO:VIMIAN)

Now 22% undervalued after recent price drop

Is Vimian Group AB (publ) (STO:VIMIAN) Trading At A 34% Discount?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Vimian Group AB (publ) to Report Q2, 2022 Results on Aug 11, 2022

Less than half of directors are independent

Erträge & Einnahmen